Caspase 3 and 7 Mediate Cytoprotective Autophagy and DNA Damage Response in Human Breast Cancer Cells

Study Background and Research Question

Adaptation to cellular stress is fundamental to cancer cell survival and progression. While caspases are classically recognized for executing apoptosis, mounting evidence suggests these cysteine-dependent aspartic proteases also regulate non-apoptotic processes, including autophagy and DNA repair. Prior work in Drosophila established a role for effector caspases in cytoprotective autophagy, but parallels in human cancer biology remained unexplored. The reference study by Samarasekera et al. (PLoS Biology, 2025) addresses whether human caspase 3 (CASP3) and caspase 7 (CASP7) orchestrate similar adaptive responses to non-lethal stress in breast cancer cells.

Key Innovation from the Reference Study

The primary innovation of the study is the demonstration that CASP3 and CASP7 promote cytoprotective autophagy and coordinate the DNA damage response in human breast cancer cells exposed to metabolic or proteostatic stress. Notably, the authors uncover a non-canonical processing pathway for CASP7 under non-lethal stress, generating stable fragments (CASP7-p29/p30) that can rescue DNA damage signaling even when both CASP3 and CASP7 are knocked out. This work directly connects effector caspases to autophagic flux and DNA repair, challenging the apoptosis-centric view of caspase function and highlighting their importance in cancer cell stress adaptation.

Methods and Experimental Design Insights

The investigation centers on well-characterized human breast cancer cell lines subjected to nutrient starvation or proteasome inhibition—conditions that model non-lethal cellular stress. The researchers employed CRISPR/Cas9-mediated knockout of CASP3 and CASP7, both individually and in combination, to dissect their roles. Key endpoints included measurement of autophagy markers (LC3B, ATG7), DNA damage response indicators (H2AX phosphorylation), and proteolytic processing of PARP1, a central DNA repair enzyme. The study also leveraged expression of CASP7-p29/p30 fragments to assess their sufficiency in restoring DNA damage signaling. Synthetic lethality was tested in the context of BRCA1 deficiency, further linking caspase function to DNA repair pathways.

Core Findings and Why They Matter

• Effector Caspase-Driven Autophagy: Loss of CASP3 and CASP7 impaired cytoprotective autophagy under stress, as evidenced by decreased LC3B and ATG7 transcript levels, underscoring a functionally conserved mechanism with Drosophila models (Samarasekera et al.).
• DNA Damage Response Coordination: Double knockout of CASP3 and CASP7 led to reduced H2AX phosphorylation and increased PARP1 cleavage, indicating compromised DNA damage signaling.
• Non-Canonical CASP7 Processing: Under non-lethal stress, CASP7 underwent calpain-dependent cleavage at specific sites flanking a PARP1 exosite, producing stable p29/p30 fragments. Remarkably, these fragments were sufficient to restore H2AX phosphorylation in CASP3/7-deficient cells.
• Synthetic Lethality with BRCA1 Loss: Cells deficient in CASP3 and CASP7 exhibited synthetic lethality when BRCA1 was also lost, further implicating these caspases in DNA repair and stress resistance mechanisms relevant to cancer therapy.

Together, these results establish effector caspases as mediators of cytoprotective autophagy and genome integrity maintenance under sublethal stress, expanding therapeutic targets beyond apoptotic pathways.

Comparison with Existing Internal Articles

Several recent resources explore the mechanistic intersections of Nicotinamide Adenine Dinucleotide (NAD+) with metabolic signaling, autophagy, and DNA repair workflows. For example, "Redefining NAD+: Strategic Insights for Metabolic Stress Research" contextualizes NAD+ as a central mediator of energy regulation and autophagy, aligning with the current study's focus on cellular adaptation to stress. Furthermore, "Nicotinamide Adenine Dinucleotide (NAD+): Precision in Metabolic and Autophagy Research" details NAD+'s dual role in autophagy and DNA repair, providing actionable protocol enhancements compatible with the workflows described by Samarasekera et al. The present study complements these perspectives by elucidating how effector caspases interface with autophagy and DNA repair machinery, potentially converging mechanistically with NAD+-dependent signaling and sirtuin activity. These intersections suggest that integrating high-purity NAD+ as an experimental reagent can refine the dissection of metabolic and stress adaptation pathways in cancer models.

Limitations and Transferability

While the findings offer strong evidence for caspase-mediated cytoprotective autophagy and DNA damage response in breast cancer cells, several limitations must be considered. First, the experiments were conducted in vitro using established cell lines, which may not fully recapitulate the tumor microenvironment or heterogeneous stress responses found in vivo. Second, the study focuses on non-lethal stressors; it remains unclear whether similar caspase functions persist under more severe or chronic stress. Finally, the synthetic lethality observed with BRCA1 loss underscores potential therapeutic avenues but requires validation in animal models and primary tumor samples before translational application.

Protocol Parameters

• CRISPR/Cas9 knockout of CASP3 and CASP7: Lentiviral transduction followed by puromycin selection; validate knockout efficiency by immunoblotting.
• Stress induction: Starvation induced by culturing cells in HBSS for 2–6 hours; proteasome inhibition using MG-132 (10 μM) for 6–24 hours.
• Autophagy assessment: Monitor LC3B-II accumulation by immunoblot; quantify ATG7 and LC3B mRNA by qPCR.
• DNA damage response: Detect γH2AX (H2AX phosphorylation) by immunofluorescence or immunoblotting.
• Rescue experiments: Express CASP7-p29/p30 fragments via transient plasmid transfection; confirm expression with specific antibodies.
• PARP1 cleavage monitoring: Use immunoblotting to detect cleaved PARP1 in response to stress in wild-type and knockout cells.

Research Support Resources

To facilitate advanced studies on metabolic signaling, autophagy, and DNA repair, researchers can incorporate Nicotinamide Adenine Dinucleotide (NAD+) (SKU B1793) from APExBIO into their experimental workflows. NAD+ acts as an essential cofactor in redox reactions, sirtuin-mediated protein deacetylation, and PARP1-dependent DNA repair—key processes highlighted in the reference study. For detailed protocol recommendations and troubleshooting relevant to NAD+-dependent assays, the articles here and here provide practical insights. APExBIO’s high-purity NAD+ is well suited for ensuring reproducibility and accuracy in metabolic and stress adaptation research.